Mark R. Openshaw

528 total citations
27 papers, 350 citations indexed

About

Mark R. Openshaw is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Mark R. Openshaw has authored 27 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Mark R. Openshaw's work include Cancer Genomics and Diagnostics (10 papers), Genetic factors in colorectal cancer (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Mark R. Openshaw is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Genetic factors in colorectal cancer (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Mark R. Openshaw collaborates with scholars based in United Kingdom, Italy and United States. Mark R. Openshaw's co-authors include Heather Knight, Gareth Warren, Marc R. Knight, Jacqui Shaw, David W. Galbraith, Michael K. Deyholos, David S. Guttery, David J. Pinato, Karen Page and Daniel Fernández-García and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and The Plant Journal.

In The Last Decade

Mark R. Openshaw

25 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Openshaw United Kingdom 11 92 90 86 71 52 27 350
Hong Jae Jo South Korea 11 91 1.0× 44 0.5× 32 0.4× 27 0.4× 122 2.3× 24 320
Takako Miyamura Japan 12 86 0.9× 154 1.7× 20 0.2× 52 0.7× 34 0.7× 57 457
Gordon P. Watt United States 12 66 0.7× 47 0.5× 83 1.0× 10 0.1× 21 0.4× 27 301
Ann G. Schwartz United States 4 142 1.5× 57 0.6× 64 0.7× 7 0.1× 71 1.4× 5 369
Estelamari Rodríguez United States 10 191 2.1× 126 1.4× 76 0.9× 14 0.2× 35 0.7× 50 376
Yong‐Qiao He China 12 128 1.4× 133 1.5× 63 0.7× 9 0.1× 36 0.7× 35 377
Wendy Wood United Kingdom 12 92 1.0× 238 2.6× 23 0.3× 9 0.1× 70 1.3× 21 514
Henning Feist Germany 11 187 2.0× 237 2.6× 74 0.9× 9 0.1× 40 0.8× 30 572
Aine Clements United States 13 136 1.5× 90 1.0× 66 0.8× 8 0.1× 78 1.5× 27 422
Andrew Dunford United States 6 115 1.3× 183 2.0× 54 0.6× 19 0.3× 24 0.5× 17 424

Countries citing papers authored by Mark R. Openshaw

Since Specialization
Citations

This map shows the geographic impact of Mark R. Openshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Openshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Openshaw more than expected).

Fields of papers citing papers by Mark R. Openshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Openshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Openshaw. The network helps show where Mark R. Openshaw may publish in the future.

Co-authorship network of co-authors of Mark R. Openshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Openshaw. A scholar is included among the top collaborators of Mark R. Openshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Openshaw. Mark R. Openshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abraham, Jean, Katie Snape, Katrina Tatton‐Brown, et al.. (2023). Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists. Clinical Medicine. 23(1). 9–15. 11 indexed citations
3.
Fulgenzi, Claudia Angela Maria, Bernhard Scheiner, Alessandra Gennari, et al.. (2023). Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials. JHEP Reports. 5(5). 100702–100702. 34 indexed citations
4.
Openshaw, Mark R., et al.. (2023). Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis. Journal of Translational Medicine. 21(1). 283–283. 2 indexed citations
5.
Joekes, Katherine, et al.. (2023). Evaluation of two Massive Open Online Courses (MOOCs) in genomic variant interpretation for the NHS workforce. BMC Medical Education. 23(1). 540–540. 4 indexed citations
6.
Openshaw, Mark R., et al.. (2022). Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy. Journal of Gastrointestinal Cancer. 54(3). 768–775. 1 indexed citations
7.
Maher, Geoffrey J., Rosemary A. Fisher, Baljeet Kaur, et al.. (2022). Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours. npj Genomic Medicine. 7(1). 26–26. 6 indexed citations
8.
Fulgenzi, Claudia Angela Maria, Antonio D’Alessio, Thomas Talbot, et al.. (2022). New Frontiers in the Medical Therapy of Hepatocellular Carcinoma. Chemotherapy. 67(3). 164–172. 11 indexed citations
9.
Page, Karen, Luke Martinson, Daniel Fernández-García, et al.. (2021). Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease. JCO Precision Oncology. 5(5). 1768–1776. 22 indexed citations
10.
Personeni, Nicola, Ana Lleò, Tiziana Pressiani, et al.. (2020). Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options. Cancers. 12(11). 3370–3370. 32 indexed citations
11.
Openshaw, Mark R. & Terri McVeigh. (2020). Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers. Frontiers in Digital Health. 2. 573010–573010. 6 indexed citations
12.
Openshaw, Mark R., Ali Abdulnabi Suwaidan, Daniel Fernández-García, et al.. (2020). Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma. British Journal of Cancer. 123(8). 1271–1279. 30 indexed citations
13.
Smith, Katherine, Myria Galazi, Mark R. Openshaw, et al.. (2019). The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer. Clinical Genitourinary Cancer. 18(3). e217–e223. 3 indexed citations
14.
Openshaw, Mark R., et al.. (2018). Developing the liquid biopsy in gastroesophageal adenocarcinoma: Disease monitoring and detection of minimal residual disease. Annals of Oncology. 29. viii662–viii662. 3 indexed citations
15.
Openshaw, Mark R., C. J. Richards, David S. Guttery, Jacqui Shaw, & Anne Thomas. (2017). The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring. Expert Review of Molecular Diagnostics. 17(5). 459–470. 9 indexed citations
16.
Openshaw, Mark R., Richard Harvey, Neil J. Sebire, et al.. (2015). Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors. EBioMedicine. 4. 146–152. 24 indexed citations
17.
Openshaw, Mark R., Christina Fotopoulou, Sarah P. Blagden, & Hani Gabra. (2015). The Next Steps in Improving the Outcomes of Advanced Ovarian Cancer. Women s Health. 11(3). 355–367. 8 indexed citations
18.
Openshaw, Mark R., et al.. (2013). Atypical Hypertrophic Osteoarthropathy as a Presenting Complaint in a Non-Smoker. Journal of Medical Cases. 4(4). 204–207. 1 indexed citations
19.
Flint, Julia, et al.. (2010). Self‐management strategies used during flares of rheumatoid arthritis in an ethnically diverse population. Musculoskeletal Care. 8(4). 204–214. 24 indexed citations
20.
Knight, Heather, Michael K. Deyholos, Mark R. Openshaw, et al.. (2003). The sfr6 mutant of Arabidopsis is defective in transcriptional activation via CBF/DREB1 and DREB2 and shows sensitivity to osmotic stress. The Plant Journal. 34(4). 395–406. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Jae Jo Breakdown of academic impact, for papers by Takako Miyamura Breakdown of academic impact, for papers by Gordon P. Watt Breakdown of academic impact, for papers by Ann G. Schwartz Breakdown of academic impact, for papers by Estelamari Rodríguez Breakdown of academic impact, for papers by Yong‐Qiao He Breakdown of academic impact, for papers by Wendy Wood Breakdown of academic impact, for papers by Henning Feist Breakdown of academic impact, for papers by Aine Clements Breakdown of academic impact, for papers by Andrew Dunford
Rankless by CCL
2026